Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001415889-25-009616

Director acquired 1,210 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LEVIN ARTHUR A Director 2025-03-31 Option exercise +1,210 1,210 D
Derivatives
LEVIN ARTHUR A Director 2025-03-31 Option exercise · Restricted Stock Units −1,210 3,632 D
Loading xslF345X05/form4-04022025_080412.xml…